Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huoxinwan for Stable Angina in Coronary Heart Disease
ChiCTR-IPR-17010929Phase 4Completed
- Sponsor
- Fuwai Hospital
- Start
- Dec 2014
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in coronary arteriosclerosis and stable angina comparing Huoxinwan with Placebo (2 arms). Primary endpoint: Angina attack frequency. Started Dec 2014; status: completed.
02
Drugs
Huoxin Pill
03
Conditions
coronary arteriosclerosisstable angina
Beyond the preview
Go deeper on ChiCTR-IPR-17010929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17010929.